DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis
Europe - FRA:DMP - DE000A2GS5D8 - Common Stock
35.1 EUR
-0.2 (-0.57%)
Overall DMP gets a fundamental rating of 5 out of 10. We evaluated DMP against 54 industry peers in the Pharmaceuticals industry. DMP has a medium profitability rating, but doesn't score so well on its financial health evaluation. DMP has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
DMP had positive earnings in the past year.
In the past year DMP had a positive cash flow from operations.
DMP had positive earnings in each of the past 5 years.
DMP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
DMP has a Return On Assets (5.02%) which is in line with its industry peers.
With a decent Return On Equity value of 17.62%, DMP is doing good in the industry, outperforming 61.11% of the companies in the same industry.
DMP has a Return On Invested Capital (7.50%) which is comparable to the rest of the industry.
DMP had an Average Return On Invested Capital over the past 3 years of 9.78%. This is below the industry average of 14.51%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.02% | ||
| ROE | 17.62% | ||
| ROIC | 7.5% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
1.3 Margins
The Profit Margin of DMP (9.11%) is comparable to the rest of the industry.
DMP's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 18.55%, DMP is in line with its industry, outperforming 51.85% of the companies in the same industry.
In the last couple of years the Operating Margin of DMP has grown nicely.
DMP has a Gross Margin (65.67%) which is in line with its industry peers.
In the last couple of years the Gross Margin of DMP has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.55% | ||
| PM (TTM) | 9.11% | ||
| GM | 65.67% |
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DMP is creating some value.
DMP has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for DMP remains at a similar level compared to 5 years ago.
Compared to 1 year ago, DMP has a worse debt to assets ratio.
2.2 Solvency
DMP has an Altman-Z score of 2.10. This is not the best score and indicates that DMP is in the grey zone with still only limited risk for bankruptcy at the moment.
DMP has a Altman-Z score of 2.10. This is in the lower half of the industry: DMP underperforms 62.96% of its industry peers.
The Debt to FCF ratio of DMP is 5.76, which is a neutral value as it means it would take DMP, 5.76 years of fcf income to pay off all of its debts.
DMP has a Debt to FCF ratio (5.76) which is comparable to the rest of the industry.
DMP has a Debt/Equity ratio of 1.52. This is a high value indicating a heavy dependency on external financing.
DMP has a Debt to Equity ratio of 1.52. This is in the lower half of the industry: DMP underperforms 75.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.52 | ||
| Debt/FCF | 5.76 | ||
| Altman-Z | 2.1 |
ROIC/WACC1.17
WACC6.39%
2.3 Liquidity
DMP has a Current Ratio of 1.84. This is a normal value and indicates that DMP is financially healthy and should not expect problems in meeting its short term obligations.
DMP's Current ratio of 1.84 is fine compared to the rest of the industry. DMP outperforms 70.37% of its industry peers.
A Quick Ratio of 0.87 indicates that DMP may have some problems paying its short term obligations.
With a Quick ratio value of 0.87, DMP perfoms like the industry average, outperforming 42.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.84 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
DMP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.17%, which is quite impressive.
Measured over the past years, DMP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.07% on average per year.
The Revenue has been growing slightly by 3.98% in the past year.
The Revenue has been growing by 11.00% on average over the past years. This is quite good.
EPS 1Y (TTM)29.17%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%21.61%
Revenue 1Y (TTM)3.98%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-2.74%
3.2 Future
Based on estimates for the next years, DMP will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.67% on average per year.
DMP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.09% yearly.
EPS Next Y13%
EPS Next 2Y11.96%
EPS Next 3Y11.07%
EPS Next 5Y14.67%
Revenue Next Year-0.58%
Revenue Next 2Y1.65%
Revenue Next 3Y2.36%
Revenue Next 5Y3.09%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.64 indicates a rather expensive valuation of DMP.
The rest of the industry has a similar Price/Earnings ratio as DMP.
DMP's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.47.
DMP is valuated correctly with a Price/Forward Earnings ratio of 13.69.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DMP indicates a somewhat cheap valuation: DMP is cheaper than 61.11% of the companies listed in the same industry.
DMP is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.42, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.64 | ||
| Fwd PE | 13.69 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DMP is valued a bit cheaper than 72.22% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DMP indicates a rather cheap valuation: DMP is cheaper than 87.04% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.78 | ||
| EV/EBITDA | 9.04 |
4.3 Compensation for Growth
DMP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.36
PEG (5Y)2.19
EPS Next 2Y11.96%
EPS Next 3Y11.07%
5. Dividend
5.1 Amount
DMP has a Yearly Dividend Yield of 2.67%.
Compared to an average industry Dividend Yield of 3.01, DMP pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, DMP has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.67% |
5.2 History
The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
DMP pays out 44.20% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of DMP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP44.2%
EPS Next 2Y11.96%
EPS Next 3Y11.07%
FRA:DMP (11/20/2025, 3:36:57 PM)
35.1
-0.2 (-0.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners12.94%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.89B
Revenue(TTM)1.18B
Net Income(TTM)107.20M
Analysts78.18
Price Target43.25 (23.22%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.67% |
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP44.2%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.37%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.64 | ||
| Fwd PE | 13.69 | ||
| P/S | 1.61 | ||
| P/FCF | 10.78 | ||
| P/OCF | 8.77 | ||
| P/B | 3.11 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.04 |
EPS(TTM)1.99
EY5.67%
EPS(NY)2.56
Fwd EY7.3%
FCF(TTM)3.26
FCFY9.28%
OCF(TTM)4
OCFY11.41%
SpS21.86
BVpS11.3
TBVpS-8.64
PEG (NY)1.36
PEG (5Y)2.19
Graham Number22.49
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.02% | ||
| ROE | 17.62% | ||
| ROCE | 12.3% | ||
| ROIC | 7.5% | ||
| ROICexc | 8.28% | ||
| ROICexgc | 24.86% | ||
| OM | 18.55% | ||
| PM (TTM) | 9.11% | ||
| GM | 65.67% | ||
| FCFM | 14.9% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexgc growth 3Y-9.69%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score8
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.52 | ||
| Debt/FCF | 5.76 | ||
| Debt/EBITDA | 3.05 | ||
| Cap/Depr | 47.34% | ||
| Cap/Sales | 3.41% | ||
| Interest Coverage | 4.1 | ||
| Cash Conversion | 71.11% | ||
| Profit Quality | 163.6% | ||
| Current Ratio | 1.84 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 2.1 |
F-Score8
WACC6.39%
ROIC/WACC1.17
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)29.17%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%21.61%
EPS Next Y13%
EPS Next 2Y11.96%
EPS Next 3Y11.07%
EPS Next 5Y14.67%
Revenue 1Y (TTM)3.98%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-2.74%
Revenue Next Year-0.58%
Revenue Next 2Y1.65%
Revenue Next 3Y2.36%
Revenue Next 5Y3.09%
EBIT growth 1Y14.2%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.14%
EBIT Next 3Y20.11%
EBIT Next 5Y7.89%
FCF growth 1Y-34.18%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-28.97%
OCF growth 3Y-7%
OCF growth 5Y14.89%
DERMAPHARM HOLDING SE / DMP.DE FAQ
What is the fundamental rating for DMP stock?
ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE.
What is the valuation status for DMP stock?
ChartMill assigns a valuation rating of 5 / 10 to DERMAPHARM HOLDING SE (DMP.DE). This can be considered as Fairly Valued.
How profitable is DERMAPHARM HOLDING SE (DMP.DE) stock?
DERMAPHARM HOLDING SE (DMP.DE) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for DMP stock?
The Price/Earnings (PE) ratio for DERMAPHARM HOLDING SE (DMP.DE) is 17.64 and the Price/Book (PB) ratio is 3.11.
What is the earnings growth outlook for DERMAPHARM HOLDING SE?
The Earnings per Share (EPS) of DERMAPHARM HOLDING SE (DMP.DE) is expected to grow by 13% in the next year.